Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Tag Archives: september

The Silver Age of Antibiotics...
November 1, 2014 - Featured , In the News / Politics

By: Andrew Leong, Staff Writer — This year, the FDA approved three new antibiotics to treat acute bacterial skin and skin structure infections (ABSSSI) caused by Staphylococcus aureus, including MRSA. They are dalbavancin (DalvanceTM), tedizolid phosphate (SivextroTM), and oritavancin (OrbactivTM). Dalbavancin was approved on May 23, 2014 and is administered intravenously in two doses (1000…

Pradaxa® vs Warfarin...
November 1, 2014 - Featured , In the News / Politics

By: Kevin Lin, PharmD Candidate c/o 2015 — The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran) to warfarin for rates of ischemic stroke, intracranial hemorrhage, major gastrointestinal bleed, myocardial infarction, and death. The study enrolled more than 134,000 patients, with 64% over the age of 65 and found a lower risk…

Accountable Care Organizations...
November 1, 2014 - Featured , In the News / Politics

By: Stephanie Chiu and Elissa Tam, PharmD Candidates c/o 2015 — According to the Dartmouth Atlas project, health care spending in the United States has risen dramatically and yet health outcomes are not improving; meanwhile, many other countries that spend far less per person than the United States have better health outcomes.1 Studies have since…

Anticoagulation in Pregnant Women: Which Medications ar...
October 1, 2014 - Clinical , Featured

By: Diana Gritsenko, PharmD Candidate 2015 – Multiple complications can arise during pregnancy. While venous thromboembolism (VTE) has a prevalence rate of just 0.06% it is one of the leading causes of maternal mortality. It is recommended that at-risk pregnant women receive anticoagulation therapy for a minimum of 3 months and VTE prophylaxis for the…

Quantifying the Benefits of Pharmacist Prescribing Powe...
July 1, 2014 - Featured , Professional Advice / Opinions

By Davidta Brown, Senior Staff Editor – The idea of granting pharmacists the right to prescribe, as well as to counsel and dispense, has long been a source of controversy among healthcare professionals. A study out of the University of Alberta in Canada, published online in mid-April, provided some much needed concrete data for an…

The Importance of the Measles Vaccine: Should We Be Vac...
July 1, 2014 - Featured , In the News / Politics

By: Sherin Pathickal, PharmD Candidate c/o 2016 – The mandatory receipt of vaccinations as a preventive public health measure has long been a controversial issue in our society.1 Despite the popular use of immunizations, many reservations about vaccine constituents and their safety have prevailed, leading to increasing numbers of unvaccinated people.1 Opponents of vaccinations have…

Antipsychotic Use in the Elderly with Dementia...
July 1, 2014 - Clinical , Featured

By: Ada Seldin, Staff Editor – The overuse of antipsychotics in the nursing home population for off-label indications continues to impact patient safety. In 2005, the FDA issued a black box warning that stated, “The treatment of behavioral disorders in elderly patients with dementia with atypical antipsychotic medications is associated with increased mortality.” The evidence…

New Legislation Redefines Oversight for Compounding Pha...
April 1, 2014 - Featured , In the News / Politics

By: Davidta Brown, Senior Staff Editor – As the world of healthcare and its provision evolves, laws which organize and oversee the ways that patients receive health services must develop at the same pace. Last November, a new bill establishing clearer protocol for the compounding and tracking of medications became national law. The Drug Quality…

The Status of Surveillance of Japanese Encephalitis in ...
March 1, 2014 - Featured , In the News / Politics

By: Sabrina Ahmed, PharmD Candidate c/o 2017 – One recent stride towards combating worldwide infectious disease has been in the improved surveillance of Japanese encephalitis in Asia, predominantly in South and South-East Asia. This potentially deadly virus is transmitted to humans via mosquito bites. The Japanese encephalitis (JE) virus is the leading cause of encephalitis…

Methadone Associated Arrhythmias on the Rise...
March 1, 2014 - In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Methadone maintenance therapy is prescribed for opioid dependency. Many HIV patients who were former injection drug abusers rely on methadone maintenance. Although there is limited data, research suggests lamivudine, ritonavir, and zidovudine to be the most common concomitant drugs in methadone associated torsades and prolonged QT interval.1…

To Defend the People...
February 1, 2014 - Featured , Professional Advice / Opinions

By: Davidta Brown, Senior Staff Editor – As the world’s largest market for pharmaceuticals, the United States receives many medications manufactured abroad.1 Patients, physicians, and pharmacists defer the responsibility of ensuring the quality of these imported drugs to the FDA, but it only takes one report of deceit in the pharmaceutical industry for this trust…

Low Literacy and Medication Management?...
February 1, 2014 - Professional Advice / Opinions

By: Jenny Park, Pharm. D. Candidate c/o 2015 – As the Affordable Care Act brings health care to many people who are currently uninsured, healthcare providers should expect an increase in the number of patients who don’t understand their plan, disease states, and medications. Health literacy is defined as “the degree to which individuals have…

Dengue Fever: Where Do We Go From Here?...
February 1, 2014 - In the News / Politics

By: Sherin Pathickal, PharmD Candidate c/o 2016 – Dengue Fever, widely known as “break-bone fever,” is an illness that causes pain in the joints and muscles, and is often described by those infected as comparable to the feeling of breaking a bone.1 It is spread by mosquitoes and has a painful array of symptomology such…

Asperger Syndrome: Temple Grandin’s Insight and Contr...
January 1, 2014 - Events

By: Sang Hyo Kim, Staff Editor – During the Fall 2013 semester, activist and bestselling author Temple Grandin, Ph.D, came to St. John’s University to talk to students, faculty, and administrators about the need to embrace children and young adults who have autism spectrum disorders (ASDs). While many people may think of autism as a…

Possible Inhaled Option for Diabetics...
December 1, 2013 - In the News / Politics

By: Sang Hyo Kim, Staff Editor – Near the end of December, the pharmaceutical company, MannKind Corp, will submit their clinical data to the U.S Food and Drug Administration for the approval of an inhaled dosage form of insulin, Afrezza®.1 Administered with the Dreamboat inhaler, this inhaled dosage form delivers insulin packaged into single dose…

Hospital Drug Shortages...
December 1, 2013 - Featured , In the News / Politics

By: Hamid Razaki, PharmD – Drug shortages seen across pharmacies in the United States continue to be an issue in patient care. A drug product shortage is defined as a supply issue that affects how the pharmacy prepares or dispenses a drug product, or that influences patient care when prescribers must use an alternative agent.1…

Expanding a Technician’s Role...
December 1, 2013 - Professional Advice / Opinions

By: Sang Hyo Kim, Staff Editor – Pharmacy, like much of medicine, is constantly changing, and the new changes in pharmacy practice are even happening to technicians. While there were originally no national standards for pharmacy-technician education and training, the American Society of Health-System Pharmacists (ASHP) and the Accreditation Council for Pharmacy Education (ACPE) have…

Possible Mandatory Lung Cancer Screening...
December 1, 2013 - Featured , In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Lung cancer takes away the lives of about 160,000 individuals annually, which is more than a quarter of all cancer deaths.1 The U.S Preventive Service Task Force is now recommending lung cancer screenings for heavy smokers which could save up to 20,000 lives a year (or about 13%…

Provider Status for Pharmacists: Call to Action or Dist...
December 1, 2013 - Featured , In the News / Politics

By: Samantha Schmidt, PharmD Candidate c/o 2014, Palm Beach Atlantic University – The role of pharmacists in healthcare has grown exponentially over the years. Pharmacists now provide advanced patient-centered care services including coordination of medications during transitions of care, comprehensive medication reviews with medication monitoring, chronic disease management, disease education, prevention and wellness services, and…

Advancements Towards a Malaria Vaccine...
November 1, 2013 - In the News / Politics

By: Sang Hyo Kim, Staff Editor – A new experimental vaccine, PfsPZ, offers great promise as a cure for malaria. PfsPZ demonstrated 100% success in protecting subjects from this mosquito-borne tropical disease, which affects about 200 million people and causes 660,000 death annually.1,2 Historically, it has been known that sustained immunity for malaria could be…

Middle East Respiratory Syndrome (MERS)...
November 1, 2013 - In the News / Politics

By: Uzma Toppa, PharmD Candidate c/o 2014 – Middle East Respiratory Syndrome, also known as MERS, is a viral respiratory illness caused by a coronavirus called MERS-CoV. It was first reported in humans in Saudi Arabia in 2012. According to the World Health Organization (WHO), from September 2012 to September 2013, there have been a…

Zecuity(TM): Novel Treatment Option for Migraines...
November 1, 2013 - Clinical

By: Arya Mathew, PharmD Candidate c/o 2014 –  About twelve percent of the U.S. population suffers from migraines, affecting adult women three times more than adult men.  Migraines are returning attacks of moderate to severe, throbbing or pulsing pain, usually on one side of the head.  Along with the severe pain, migraine sufferers also experience…

The Third Wheel or the Steering Wheel? Pharmacists on t...
November 1, 2013 - Professional Advice / Opinions

By: Joshua Bliss, PharmD Candidate c/o 2016 – Doctor – a word often utilized by both professionals and the general public alike to describe a physician. “Doctor” finds its origins in the Latin word for “teacher.” The word “physician,” however, carries a more complicated origin. It is derived from Latin’s “physicum,” meaning remedy.1 In Luke…

“Cowcatcher” Enzyme Catching Medical Attention...
November 1, 2013 - Featured , In the News / Politics

By: Ansel Oommen, BS Toxicology Candidate c/o 2014 – DNA damage is the driving force behind aging, and, on a more serious note, the development of cancers.1 While the stresses of life can be taxing on cells, the human body possesses a remarkable repair mechanism to remedy them. Researchers from the University of Texas Medical…

New Drug to Treat HIV-1 Hits the Market...
October 1, 2013 - Clinical , Featured

By: Ada Seldin, Staff Editor – On August 12,2013, a new weapon against HIV-1 infection was added to the existing armada. Dolutegravir, the third integrase strand transfer inhibitor to attain FDA approval, targets a protein essential to HIV replication. HIV-1 is the predominant type of HIV virus, the other being HIV-2, which is endogenous to…

BRAIN Initiative: Mapping the Human Brain...
October 1, 2013 - Featured , In the News / Politics

By Erica Dimitropoulos, Senior Staff Editor – If you were in charge of government spending, how would you allocate our funds? Would you put more money into public schools? Restructure the healthcare system? How about a multi-billion dollar project to remap the brain? A few months ago, President Obama announced his plans to invest in…

A Close Concurrence on Certolizumab (Cimzia®)...
September 1, 2013 - Clinical , Featured

By: Sang Hyo Kim, Staff Editor – This year, on July 23rd, FDA advisers voted 7 to 6, with one abstention, in favor of approving the drug certolizumab (Cimzia®) for the indication of axial spondyloarthritis (axSpA). axSpA is a chronic imflammatory condition that includes ankylosing spondylitis (AS) and non-radiographic axial spndyloarthristis (nr-axSpA).1,2 axSpA, AS and…

AUVI-Q™: The Newest Epinephrine Device to Hit the Mar...
May 1, 2013 - In the News / Politics

By: Diana Gritsenko, Pharm D. Candidate c/o 2015 – Most of us who work in a community pharmacy setting will usually get a few scripts a month for an Epi-pen™.  An Epi-pen™ is a device that autoinjects epinephrine (also known as adrenaline) into a patient who is experiencing anaphylaxis. Anaphylaxis is a severe, whole-body allergic…

College of Pharmacy and Health Sciences Collaborates...
February 1, 2013 - In the News / Politics

By:  Tasnima Nabi, Associate Student Editor – St. John’s University College of Pharmacy and Health Sciences has collaborated with the Union Square Academy of Health Sciences (U. S. A.) to prepare high school students for the pharmacy profession.  This partnership is one of the many projects of the “Urban Pharmaceutical Care, Research and Education Institute,”…

The Opioid Debate: PROP and PROMPT Battle Away...
January 1, 2013 - Featured , In the News / Politics

By: Tamara Yunusova – On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing (PROP) called on the FDA to implement opioid label changes that would restrict Chronic Non-Cancer (CNCP) opioid treatment for patients with severe pain only.  It wasn’t too long before another petition signed by PROP’s adversary,…

Are You Prepared for RSV Season?...
November 1, 2012 - Clinical , In the News / Politics

By: Mahdieh Danesh Yazdi, Associate Student Editor – Many of us have prepared for influenza season by receiving the flu vaccine.  (If you have not, please speak to your doctor or pharmacist soon!  Remember: even if you do not need it for your protection, get it for your patients’ well-being).  However, for the youngest members…

New Drug Review: Tofacitinib (Xeljanz®)...
November 1, 2012 - Clinical

By: Jessica Lee, PharmD Candidate c/o 2013 – Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system attacks healthy tissue, causing inflammation of the joints and potential harm to other organs.1  It affects 0.5-1% of the adult population and is more prevalent in the seventh decade of life.1  These patients tend to…

Duloxetine’s Effect on Blood Glucose Levels...
October 1, 2012 - Clinical , Featured

By: Neal Shah, Co-Editor-in-Chief – Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US market in 2004, indicated for the treatment of diabetic neuropathic pain.1 A chemical figure of duloxetine is shown [in the PDF].2 It was developed in an effort to mimic tricyclic antidepressant mitigation of neuropathic pain…

The Role of NMDA in Electroconvulsive Therapy and Other...
October 1, 2012 - Clinical , Featured

By: Neal Shah, Co-Editor-in-Chief – Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other neuropsychological disorders.1 By inducing a seizure, neurotransmitters are released and the disease state may feature a modest mitigation in symptoms.1 Seizure medications such as benzodiazepines and barbiturates are prescribed to increase or heighten the seizure…

Studying Abroad: The Perspective From a Pharmacy Studen...
October 1, 2012 - Professional Advice / Opinions

By: Shannon Tellier – When applying to St. John’s University College of Pharmacy and Health Sciences five years ago, I never would have dreamed that I would have the opportunity to study abroad twice while obtaining my PharmD degree. At the end of my freshmen year, there were rumors about second year pharmacy students having…

Rho Chi Executive Board Member Insight: Albana Alili...
September 1, 2012 - Professional Advice / Opinions

By: Mohammad A. Rattu, Pharm.D.  [PGY-1 Resident at VA NYHHS] – We sometimes need to step back and look at our foundations for success.  Without the support of past and present Rho Chi executive boards, there would be no Rho Chi Post newsletter.  From our May to September issues, we will learn about each of…

College Of Pharmacy And Health Sciences – Name Ch...
September 1, 2012 - Events , Featured , In the News / Politics

 The College of Pharmacy and Allied Health Professions has officially changed its name to the College of Pharmacy and Health Sciences.  This is the college’s second name change since it was established in 1929. In order to truly encompass the current and future educational goals of the College of Pharmacy and Allied Health Professions, the…

Rho Chi Executive Board Member Insight: Elizabeth Mo...
August 1, 2012 - Professional Advice / Opinions

By: Mohammad A. Rattu, Pharm.D.  [PGY-1 Resident at VA NYHHS] – We sometimes need to step back and look at our foundations for success.  Without the support of past and present Rho Chi executive boards, there would be no Rho Chi Post newsletter.  From our May to September issues, we will learn about each of…

The Role of N-Acetylcysteine in Contrast Induced Nephro...
August 1, 2012 - Clinical

By: Neal Shah, Co-Editor-In-Chief – Contrast dyes enhance imaging for computer tomography (CT), magnetic resonance (MR), and X-rays.1  Dyes usually consist of barium, iodine, or gadolinium, depending on the procedure.2  CT and X-ray scans often use iodine for systemic imaging and barium sulfate for GI imaging, whereas MR imaging primarily uses gadolinium.2  Gadolinium and iodine…

Rho Chi Executive Board Member Insight: Yining Shao...
July 1, 2012 - Professional Advice / Opinions

By: Mohammad A. Rattu, Pharm.D.  [PGY-1 Resident at VA NYHHS] – We sometimes need to step back and look at our foundations for success.  Clearly, without the support of past and present Rho Chi executive boards, there would be no Rho Chi Post newsletter.  From our May to September issues, we will learn about each…

Effect of Intravenous Ondansetron on QT Interval Prolon...
June 1, 2012 - Clinical

By: Raymond Wu, Pharm.D. Candidate c/o 2013   The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used in the prevention and treatment of nausea and vomiting in the inpatient setting.1  Overall, ondansetron is a well-tolerated medication with few side effects.1  Constipation, dizziness, and headache are the most commonly reported side effects associated…

Dr. Oz and Raspberry Ketones...
June 1, 2012 - Clinical , In the News / Politics , Professional Advice / Opinions

By: Lila Ahmed, Pharm.D. Candidate c/o 2013 – Whether you wish to admit it or not, all of us have watched or at least heard of the Dr. Oz Show.  I am sure that many of us encounter patients in the pharmacy who say, “I saw this on Dr. Oz; where could I find it?”…

Rho Chi Executive Board Member Insight: Bethsy M. Jacob...
June 1, 2012 - Professional Advice / Opinions

By: Mohammad A. Rattu, Pharm.D. Candidate c/o 2012 – We sometimes need to step back and look at our foundations for success.  Clearly, without the support of past and present Rho Chi executive board members, there would be no Rho Chi Post newsletter.  From our May to September issues, we will learn about each of…

Featured Organization: Urban Santa Project (USP)...
April 1, 2012 - Professional Advice / Opinions

By: Sibyl Cherian, PharmD Candidate c/o 2013 – Santhosh Cherian, is the co-founder and executive director of the Urban Humanitarian Projects (UHP). He is currently in his third year of medical school at St. George University and is completing his clinical clerkships in Brooklyn, New York. St. John’s University is a Catholic, Vincentian and metropolitan…

Express Scripts and Medco Merger...
February 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – Express Scripts Inc., one of the nation’s top pharmacy benefit managers (PBMs), has announced a $29 billion deal to take over one of its top competitors, Medco Health Solutions Inc.  Medco shareholders re-approved the merger on December 21.  For finalization, it needs the approval of Express Scripts’ shareholders and the…

FDA Challenges Pharmacists’ Right to Compound...
January 1, 2012 - Featured , In the News / Politics

By: Ebey P. Soman – With clearly established roles for pharmacists, compounding is recognized and upheld as a core foundation of the pharmacy profession.   It allows pharmacists to provide unique and tailored medication regimens for their patients.  The U.S. Food and Drug Administration (FDA) thought otherwise when the agency sued Franck’s Lab, Inc., a Florida-based…

New York Lawmakers Tackle Prescription Drug Abuse...
January 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – We have all heard the mortifying tales of recent attacks on pharmacies by addicts looking to steal prescription pain-killers. Most notable perhaps, was the case of David Laffers. Mr. Laffers walked into Haven Drugs in Medford, NY and killed the pharmacist, a store clerk, and two customers, who happened to…

Interview with Dr. Elizabeth Palillo...
December 1, 2011 - Featured , Professional Advice / Opinions

By: Mahdieh Danesh Yazdi – Dr. Elizabeth Palillo graduated from the University of Connecticut in 2006. She then worked as a manager at CVS for a year and a half, and eventually moved to New York, where she worked at two other CVS stores. Dr. Palillo then left CVS and joined Bronx-Lebanon Hospital as a…

Event Spotlight: Rho Chi General Body Meeting...
October 1, 2011 - Events

By Marie Huang – On September 22nd, members of Rho Chi gathered in Sullivan Hall Room 306 for the first General Body Meeting of the semester. As President Mohamed Dungersi stepped to the front of the room and reintroduced the executive board, students quietly helped themselves to scrumptious, hot slices of Domino‟s Pizza, and retreated…

In The News: TNF-Alpha Inhibitors Receive More Warnings...
October 1, 2011 - In the News / Politics

By Ebey P. Soman – TNF-alpha inhibitors are drugs used to treat rheumatoid arthritis, Crohn’s disease, and ulcerative colitis, as well as other disease states. These agents suppress the immune system and increase the risk of developing serious infections. Currently, there are five approved drugs in this category: • Adalimumab (Humira®, Abbott) • Certolizumab pegol…

Post navigation

← Older posts


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post